Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CYR-064
Sort By
Newest First
1 / 1
1 / 1
Announcement
Cyrano Therapeutics Launches Clinical Study of CYR-064 for Smell Loss (Hyposmia) in Parkinson's Disease Patients.
Cyrano Therapeutics
PR-01-25-NI-32
Feb 04, 2025
